Responses
Therapeutics
Randomised Controlled Trial
Low-dose rosiglitazone plus metformin reduces risk of incident type 2 diabetes compared with placebo in people with impaired glucose tolerance
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 28 February 2011
- Published on: 28 February 2011Is Rosiglitazone a safe drug?
Dear Editor,
I was surprised to see the assertion by Philip Home that rosiglitazone is a "particularly safe drug." Given its withdrawal from public use (the current prescribing ban recommended by MHRA in the UK, the European Medicines Agency and the FDA in the United States) due to concerns over increased cardiovascular risks, it would seem that our health authorities see it as anything but a safe drug.
Conflict of Interest:
None declared.